Aflastatin ACAS# 179729-59-0 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 179729-59-0 | SDF | Download SDF |
PubChem ID | 54687501 | Appearance | Powder |
Formula | C62H115NO24 | M.Wt | 1258.57 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (3E,5R)-3-[(E,4S,6R,8S,9S,10S,11R,12R,13R,14S,15R,17S,18S,19R,20S,21R,23R,25S,27S,28R,29S,30S,31R)-1,8,9,11,13,15,17,19,21,23,25,27,28,29,30,31-hexadecahydroxy-2,4,6,10,12,14,18,20-octamethyl-32-[(2R,3S,4S,5S,6S)-3,4,5,6-tetrahydroxy-6-[(2R)-2-hydroxyundecyl]oxan-2-yl]dotriacont-2-enylidene]-1,5-dimethylpyrrolidine-2,4-dione | ||
SMILES | CCCCCCCCCC(CC1(C(C(C(C(O1)CC(C(C(C(C(CC(CC(CC(C(C)C(C(C)C(CC(C(C)C(C(C)C(C(C)C(C(CC(C)CC(C)C=C(C)C(=C2C(=O)C(N(C2=O)C)C)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O | ||
Standard InChIKey | VAQYWUJSXJULKR-YLMXTBCDSA-N | ||
Standard InChI | InChI=1S/C62H115NO24/c1-12-13-14-15-16-17-18-19-38(64)28-62(86)60(84)59(83)57(81)47(87-62)27-46(72)56(80)58(82)55(79)45(71)25-40(66)23-39(65)24-41(67)32(5)50(74)33(6)42(68)26-43(69)34(7)51(75)35(8)52(76)36(9)53(77)44(70)22-30(3)20-29(2)21-31(4)49(73)48-54(78)37(10)63(11)61(48)85/h21,29-30,32-47,50-53,55-60,64-77,79-84,86H,12-20,22-28H2,1-11H3/b31-21+,49-48+/t29-,30+,32-,33-,34-,35+,36-,37+,38+,39+,40-,41+,42-,43+,44-,45-,46+,47+,50+,51+,52+,53-,55+,56-,57+,58-,59-,60-,62-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Aflastatin A is a specific inhibitor of aflatoxin production by Aspergillus parasiticus, inhibits a very early step in aflatoxin biosynthesis prior to the transcription of aflR and can influence glucose metabolism in the fungus. 2. Aflastatin A inhibits an early step in melanin production, which suppresses the expression of PKS1. 3. Aflastatin A exhibits antimicrobial activity against some bacteria, yeasts and fungi. 4. Aflastatin A has antitumor activity. |
Targets | Antifection |
Aflastatin A Dilution Calculator
Aflastatin A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 0.7946 mL | 3.9728 mL | 7.9455 mL | 15.8911 mL | 19.8638 mL |
5 mM | 0.1589 mL | 0.7946 mL | 1.5891 mL | 3.1782 mL | 3.9728 mL |
10 mM | 0.0795 mL | 0.3973 mL | 0.7946 mL | 1.5891 mL | 1.9864 mL |
50 mM | 0.0159 mL | 0.0795 mL | 0.1589 mL | 0.3178 mL | 0.3973 mL |
100 mM | 0.0079 mL | 0.0397 mL | 0.0795 mL | 0.1589 mL | 0.1986 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- N-Benzoyl-leucine
Catalog No.:BCC9092
CAS No.:17966-67-5
- Macrocarpal J
Catalog No.:BCN1139
CAS No.:179603-47-5
- Amabiline
Catalog No.:BCN1950
CAS No.:17958-43-9
- Cynaustine
Catalog No.:BCN1951
CAS No.:17958-39-3
- Cynaustraline
Catalog No.:BCN2048
CAS No.:17958-37-1
- PD 150606
Catalog No.:BCC2353
CAS No.:179528-45-1
- 1,2,3,4-Tetrahydronorharman-1-one
Catalog No.:BCN3690
CAS No.:17952-82-8
- Venoterpine
Catalog No.:BCN3422
CAS No.:17948-42-4
- Rutacridone
Catalog No.:BCN7542
CAS No.:17948-33-3
- Prucalopride Succinat
Catalog No.:BCC4708
CAS No.:179474-85-2
- Prucalopride
Catalog No.:BCC5055
CAS No.:179474-81-8
- Terrestrosin D
Catalog No.:BCN2934
CAS No.:179464-23-4
- 27-Hydroxymangiferolic acid
Catalog No.:BCN4689
CAS No.:17983-82-3
- 3-oxo-Olean-12-en-28-oic acid
Catalog No.:BCN3171
CAS No.:17990-42-0
- 7-Chlorokynurenic acid
Catalog No.:BCC6577
CAS No.:18000-24-3
- Ketohakonanol
Catalog No.:BCN7427
CAS No.:18004-20-1
- SDZ NKT 343
Catalog No.:BCC7349
CAS No.:180046-99-5
- Voafinidine
Catalog No.:BCN6738
CAS No.:180059-77-2
- SB 224289 hydrochloride
Catalog No.:BCC6976
CAS No.:180084-26-8
- Bupivacaine HCl
Catalog No.:BCC4406
CAS No.:18010-40-7
- Quercetin 3-O-glucoside-7-O-rhamnoside
Catalog No.:BCN1520
CAS No.:18016-58-5
- Megastigm-7-ene-3,4,6,9-tetrol
Catalog No.:BCN6511
CAS No.:180164-14-1
- Anthracophyllone
Catalog No.:BCN7606
CAS No.:1801750-22-0
- Ganoderlactone D
Catalog No.:BCN7849
CAS No.:1801934-15-5
Aflastatin A, a novel inhibitor of aflatoxin production by aflatoxigenic fungi.[Pubmed:9099219]
J Antibiot (Tokyo). 1997 Feb;50(2):111-8.
Aflastatin A, a novel inhibitor of the production of aflatoxin by aflatoxigenic fungi, has been isolated from the solvent extract of mycelial cake of Streptomyces sp. and its molecular formula was determined as C62H115NO24. Aflastatin A completely inhibited aflatoxin production by Aspergillus parasiticus NRRL 2999 in liquid medium or on agar plate at a concentration of 0.5 microgram/ml. The mycelial growth of this fungus was not affected in the liquid medium at the same concentration, while the hyphal extension rate was reduced on the plate together with some morphological changes. The growth of the fungus was not completely inhibited even at a concentration of 100 micrograms/ml. Aflastatin A exhibits antimicrobial activity against some bacteria, yeasts and fungi as well as antitumor activity.
Absolute configuration of aflastatin A, a specific inhibitor of aflatoxin production by Aspergillus parasiticus.[Pubmed:10813953]
J Org Chem. 2000 Jan 28;65(2):438-44.
Aflastatin A (1) is a specific inhibitor of aflatoxin production by Aspergillus parasiticus. It has the novel structure of a tetramic acid derivative with a long alkyl side chain. The absolute configurations of 29 chiral centers contained in 1 were chemically elucidated in this study. First, four small fragment molecules were prepared from 1 or its methyl ether (2), and their absolute structures were assigned as N-methyl-D-alanine, (2S,4R)-2, 4-dimethyl-1,6-hexanediol dibenzoate, (R)-3-hydroxydodecanoic acid, and (R)-1,2,4-butanetriol tribenzoate. Next, an acyclic fragment molecule 3 with 13 chiral centers was obtained from 1 by NaIO(4) oxidation, and its relative stereochemistry was elucidated by J-based configuration analysis. By analyzing coupling constants of (3)J(H,H) and (2,3)J(C,H) and ROE data, the relative configuration of 3 was verified. Finally, by further J-based configuration analysis using a fragment molecule 7 prepared from 2 with 28 chiral carbons, all relative configurations in the alkyl side chain of 1 were clarified. By connecting these relative configurations with the absolute configurations of first four fragment molecules, the absolute stereochemistry of 1 was fully determined.
Inhibitory effect of aflastatin A on melanin biosynthesis by Colletotrichum lagenarium.[Pubmed:11535802]
Microbiology. 2001 Sep;147(Pt 9):2623-8.
The effect of Aflastatin A (AsA), a novel inhibitor of aflatoxin production, on melanin biosynthesis of Colletotrichum lagenarium was examined. Addition of a low concentration of AsA (0.5 microg ml(-1)) to the culture medium almost completely inhibited the melanin production of this organism. AsA also inhibited the production of scytalone, an early intermediate of melanin biosynthesis. Melanin production was restored by addition of exogenous scytalone in the presence of AsA, suggesting that the late steps after the synthesis of scytalone were not significantly affected by AsA. This was confirmed by the results from RT-PCR analysis of the expression of genes encoding melanin biosynthetic enzymes (SCD1, THR1) and a regulatory gene (CMR1). By contrast, expression of PKS1 was severely impaired by AsA, although catalytic activity of a polyketide synthase (PKS1) was not inhibited by AsA. These results indicate that AsA inhibits an early step in melanin production, which suppresses the expression of PKS1.
Effects of aflastatin A, an inhibitor of aflatoxin production, on aflatoxin biosynthetic pathway and glucose metabolism in Aspergillus parasiticus.[Pubmed:11592501]
J Antibiot (Tokyo). 2001 Aug;54(8):650-7.
Aflastatin A inhibits aflatoxin production by Aspergillus parasiticus via an unknown mechanism. We found that Aflastatin A clearly inhibited production of norsolorinic acid, an early biosynthetic intermediate of aflatoxin, at a concentration of 0.25 microg/ml. Reverse-transcriptase polymerase chain reaction (RT-PCR), and real-time quantitative PCR (TaqMan PCR) experiments indicated that the transcription of genes encoding aflatoxin biosynthetic enzymes (pksA, ver-1, and omtA) and a gene encoding a regulatory protein for expression of the biosynthetic enzymes (aflR) were significantly reduced by the addition of Aflastatin A. We also found that Aflastatin A elevated the glucose consumption and ethanol accumulation by A. parasiticus, and repressed transcription of genes involved in ethanol utilization. These results suggest that Aflastatin A inhibits a very early step in aflatoxin biosynthesis prior to the transcription of aflR and can influence glucose metabolism in the fungus.